Vertex Technologies participated as an official sponsor of the job fair organized by the Ministry of Communications and ...

The Nasdaq 100 (^NDX) is home to some of the biggest success stories in tech and growth investing. However, certain stocks in ...

Gemini 3 Flash brings Gemini 3’s frontier reasoning to search, apps, and enterprises, combining high-speed performance with lower costs and production-ready AI at scale.

YourStory presents the daily news roundup from the Indian startup ecosystem and beyond. Here's the roundup for Thursday, December 18, 2025.

Generative AI in healthcare refers to advanced algorithms capable of generating new, original medical data or insights by learning patterns from existing datasets. These systems utilize deep learning ...

When a biotech company announces positive Phase 3 trial results or receives FDA approval, the market reaction is often immediate and substantial. This is not just speculation. These milestones ...

Shares of biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) jumped 6.2% in the afternoon session after Morgan Stanley upgraded its rating on the stock to "Overweight" from "Equal-Weight" and ...

Vertex Pharmaceuticals dominates the cystic fibrosis treatment market and recently has expanded into other therapeutic areas. The biotech predicts full-year 2025 revenue of as much as $12 billion.

Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 have been able to come off insulin altogether within a year, raising the prospect of a life without regular ...

Analysts project the U.S. diabetes market will surge past $75 billion by 2031, driven by advanced cell therapies and continuous glucose monitoring systems transforming patient care [3]. Regenerative ...